Table 4.
OR with 95% CI of developing MS for subjects with a history of IM by categories of anti-EBNA-1 antibody levels based on quantiles among controls.
| Anti-EBNA1 antibody levels (quantiles among controls) | ca/coa | OR (95% CI)b | OR (95% CI)c |
|---|---|---|---|
| <2,661 (<25) | 48/102 | 1.6 (1.1–2.3) | 1.6 (1.1–2.3) |
| 2,661–5,602 (25–50) | 122/124 | 1.7 (1.3–2.2) | 1.8 (1.4–2.4) |
| 5,603–7,951 (50–75) | 227/148 | 1.4 (1.1–1.7) | 1.4 (1.1–1.7) |
| 7,952– (75–) | 412/127 | 1.9 (1.6–2.4) | 1.9 (1.6–2.4) |
a
Number of exposed cases and controls.
b
Adjusted for age, gender, residential area, study, and ancestry.
c
Adjusted for age, gender, residential area, study, ancestry, smoking, adolescent BMI, DRB1*03:01, DRB1*13:03, DRB1*08:01, B*44:02, B*38:01, B*55:01, DQA1*01:01, DQB1*03:01, and DQB1*03:02.